BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Di L, Maiseyeu A. Low-density lipoprotein nanomedicines: mechanisms of targeting, biology, and theranostic potential. Drug Deliv 2021;28:408-21. [PMID: 33594923 DOI: 10.1080/10717544.2021.1886199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Siddiqui H, Yevstigneyev N, Madani G, Mccormick S. Approaches to Visualising Endocytosis of LDL-Related Lipoproteins. Biomolecules 2022;12:158. [DOI: 10.3390/biom12020158] [Reference Citation Analysis]
2 Han S, Mei L, Quach T, Porter C, Trevaskis N. Lipophilic Conjugates of Drugs: A Tool to Improve Drug Pharmacokinetic and Therapeutic Profiles. Pharm Res 2021;38:1497-518. [PMID: 34463935 DOI: 10.1007/s11095-021-03093-x] [Reference Citation Analysis]
3 Rakhshan S, Alberti D, Stefania R, Bitonto V, Geninatti Crich S. LDL mediated delivery of Paclitaxel and MRI imaging probes for personalized medicine applications. J Nanobiotechnology 2021;19:208. [PMID: 34256774 DOI: 10.1186/s12951-021-00955-9] [Reference Citation Analysis]
4 Salvati A, Poelstra K. Drug Targeting and Nanomedicine: Lessons Learned from Liver Targeting and Opportunities for Drug Innovation. Pharmaceutics 2022;14:217. [DOI: 10.3390/pharmaceutics14010217] [Reference Citation Analysis]